Japan, Feb. 27 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'STABILIZED ANTIBODY COMPOSITIONS AND METHODS OF PRODUCING SAME.' Other related details are as follows:
Application Number: JP,2023-167566
Category (FI): A61K9/08,A61K38/00,A61K39/395@M,A61K47/04,A61K39/395@C
Stage: PROBLEM TO BE SOLVED: To provide a stable liquid antibody composition in which occurrence or influence of deterioration of a medicine caused by oxidation is reduced, and to provide a method of producing the composition.SOLUTION: Provided is a stable liquid pharmaceutical product including a sealed container containing a recombinant protein in a liquid formulation and a headspace comprising a gas, wherein the gas contains less than 5% oxygen by volume, the recombinant protein is stable for a period of at least 28 days when stored at 45degC, and being stable for at least 28 days refers to an increase in the percentage of high molecular weight species of 2% or less over the period.SELECTED DRAWING: Figure 3 (Grant)
Filing Date: Sept. 28, 2023
Publication Date: Dec. 26, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
